Tag: Bendit21

BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021″ steerable microcatheter

Peripheral/Endo Regulatory by 0 comments

TEL AVIV, Israel, April 18, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary vasculature. The clearance was received several […]

Continue Reading →

SUCCESSFUL FIRST-IN-HUMAN USE OF BENDIT21 NEUROVASCULAR CATHETER PERFORMED AT THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

Neuro by 0 comments

TEL AVIV, Israel, Jan. 20, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment. The case involved a 57-year-old female patient who had been suffering for years from an inoperable symptomatic […]

Continue Reading →